Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 1 ... According to a study from Seoul, South Korea, "Androgen deprivation therapy is the primary treatment for advanced prostate cancer but many patients eventually ...
2009 NOV 23 ... Pipeline Updates Toremifene 80 mg to reduce fractures in men with prostate cancer on androgen deprivation therapy (ADT): In October 2009, GTx received a Complete Response Letter from the United States ...
2009 OCT 12 ... "We studied the mechanisms of estrogen/androgen involvement in the induction of NASH by treating Sprague-Dawley (SD) rats fed with a ... signal pathways underlying the molecular mechanisms for the induction process of NASH. Deprivation of endogenous estrogens and/or androgens (Tam or Flu or Tam + Flu) without the HF diet ... Liver Disease, Mental Health, Non-Alcoholic Steatohepatitis, Pharmaceuticals, Tamoxifen, Therapy, Treatment, China Agricultural University. This article was prepared by ...
2009 OCT 19 ... scientists writing in the Journal of Clinical Oncology report. "Primary androgen deprivation therapy (PADT) is frequently offered to these patients, and disease risk prediction is not ...
2009 NOV 23 ... According to a study from the United States, "Androgen deprivation therapy for prostate cancer is associated with osteoporosis and increased fracture risk. ...
2009 OCT 12 ... According to recent research from the United States, "Androgen-deprivationtherapy is commonly used in patients with progressive prostate cancer (PCa), ...
2009 NOV 2 ... Data detailed in 'Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5alpha-reductase' have been presented. "The inhibition of ... the drug produces a biochemical response in some men who progressed under androgen-deprivationtherapy, and is generally well tolerated. Achieving more potent suppression of ...
2009 OCT 12 ... A new study, 'A 16-year clinical experience with intermittent androgendeprivation for prostate cancer: oncological results,' is now available. "To present ... prostate-specific antigen (PSA) was <4 ng/ml. Criteria for resumption of hormonal therapy were PSA >20 ng/ml or clinical symptoms. Cancer specific survival curves were ...
2009 NOV 23 ... the United States, "Treatments for advanced prostate cancer (CaP) typically involve androgen deprivation therapy. However, most patients eventually develop castration-resistant CaP (CRPC) for which ...
2009 NOV 23 ... by stereotactic biopsy. Diagnosis. DCIS in a male BRCA2 mutation carrier undergoing androgen deprivation therapy for prostate cancer. Management. The patient was treated with bilateral mastectomy and ...
2009 OCT 19 ... of outcome in prostate cancer patients treated with radiotherapy (RT) +/- short-term androgendeprivation (STAD) on Radiation Therapy Oncology Group (RTOG) protocol 86-10. Here, we ...
2009 NOV 2 ... A report, 'Survival outcomes in men receiving androgen-deprivationtherapy as primary or salvage treatment for localized or advanced prostate ...
2009 NOV 16 ... radiation for medium-risk prostate cancer patients improves survival." Androgen deprivation therapy is hormone therapy used to treat prostate cancer by stopping or lowering the level of ...
2009 NOV 16 ... will provide a complement to the results of our current landmark trial." Androgen deprivation therapy is hormone therapy used to treat prostate cancer by stopping or lowering the level of ...
2009 NOV 2 ... results of an interventional radiological procedure, super-selective intraprostatic androgen deprivation therapy are discussed. This treatment has resulted in decrease in prostate volume, and serum ...
2009 NOV 23 ... According to recent research from the United States, "The profound hypogonadism due to androgen deprivation therapy for prostate cancer results in complications such as sexual dysfunction, poor quality of ...
2009 NOV 23 ... 'Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy.' According to recent research published in the Journal of General Internal Medicine, ...
2009 OCT 12 ... prostate cancer (APC). We evaluated 295 patients with APC who had initially received androgen deprivation therapy," scientists in Seoul, South Korea report. "The progression to hormone ...
